Life Science REIT halves dividend payout amid 'macroeconomic uncertainty'

2p from 4p in 2022

The uncertain macroeconomic environment has forced Life Science REIT to halve its 2023 dividend, as its portfolio valuation slumped.

In its annual results published today (26 March), the board of the £321m trust said it had decided to rebase the dividend to 2p per share, down from 4p in 2022.  The directors said the decision to slash the dividend to a level that is "sustainable and substantially covered" by adjusted earnings over time was made in the context of continuing "macroeconomic uncertainty" and interest rates expected to remain elevated.  Janus Henderson opens Global Life Sciences Strategy to UK clients "The additional financial flexibility will enable the group to effectively progress its strategy to d...